HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Isabelle Vilgrain Selected Research

Vascular System Injuries

1/2012Soluble VE-cadherin in rheumatoid arthritis patients correlates with disease activity: evidence for tumor necrosis factor α-induced VE-cadherin cleavage.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Isabelle Vilgrain Research Topics

Disease

3Breast Neoplasms (Breast Cancer)
10/2022 - 01/2017
2Hypoxia (Hypoxemia)
06/2022 - 10/2021
2Vascular Remodeling
06/2022 - 08/2014
2Kidney Neoplasms (Kidney Cancer)
12/2018 - 01/2018
2Neoplasms (Cancer)
01/2018 - 01/2013
2Rheumatoid Arthritis
12/2017 - 01/2012
2Edema (Dropsy)
08/2014 - 07/2011
2Hereditary Angioedemas
07/2014 - 07/2011
2Atrophy
10/2003 - 01/2003
1Post-Acute COVID-19 Syndrome
08/2023
1Vascular Diseases (Vascular Disease)
08/2023
1COVID-19
08/2023
1Triple Negative Breast Neoplasms
10/2022
1Atherosclerosis
06/2022
1Ocular Toxoplasmosis
10/2020
1Uveitis
10/2020
1Renal Cell Carcinoma (Grawitz Tumor)
01/2018
1Abdominal Pain (Pain, Abdominal)
01/2016
1Urticaria (Hives)
01/2016
1Rare Diseases (Rare Disease)
07/2015
1Angioedema
07/2015
1Glioma (Gliomas)
01/2013
1Brain Neoplasms (Brain Tumor)
01/2013
1Inflammation (Inflammations)
01/2012
1Vascular System Injuries
01/2012
1Body Weight (Weight, Body)
10/2003

Drug/Important Bio-Agent (IBA)

13cadherin 5IBA
08/2023 - 07/2011
5Biomarkers (Surrogate Marker)IBA
08/2023 - 01/2013
3Tyrosine (L-Tyrosine)FDA Link
10/2022 - 01/2013
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2021 - 01/2013
3BradykininIBA
01/2016 - 07/2011
2Proteins (Proteins, Gene)FDA Link
10/2022 - 10/2003
2Phosphotransferases (Kinase)IBA
06/2022 - 10/2021
2Adrenocorticotropic Hormone (ACTH)FDA Link
10/2003 - 01/2003
2Dexamethasone (Maxidex)FDA LinkGeneric
10/2003 - 01/2003
1Apolipoproteins E (ApoE)IBA
06/2022
1saracatinibIBA
06/2022
1pazopanibFDA Link
06/2022
1AcriflavineIBA
06/2022
1AntioxidantsIBA
10/2021
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
10/2021
1Immunoglobulin G (IgG)IBA
10/2020
1Retinaldehyde (Retinal)IBA
10/2020
1AntibodiesIBA
10/2020
1Hormones (Hormone)IBA
01/2018
1Tyrosine Kinase InhibitorsIBA
01/2018
1Sunitinib (Sutent)FDA Link
01/2018
1Bevacizumab (Avastin)FDA Link
01/2018
1Adalimumab (Humira)FDA Link
12/2017
1AutoantibodiesIBA
12/2017
1Etanercept (Enbrel)FDA Link
12/2017
1Matrix Metalloproteinases (MMPs)IBA
01/2013
1Metalloproteases (Metalloproteinases)IBA
01/2013
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2012
1Kallikreins (Kallikrein)IBA
07/2011
1CorticosteroneIBA
10/2003
1Angiopoietin-1IBA
10/2003
1Corticotropin Receptors (ACTH Receptor)IBA
10/2003
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
10/2003
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2003

Therapy/Procedure

1Continuous Positive Airway Pressure
10/2021
1Biological Therapy
01/2018
1Therapeutics
01/2018